The Air-Bubble Method of Locking Central-Vein Catheters with Acidified, Concentrated Sodium Chloride as a Bactericidal Agent: In Vitro Studies
Harold L. Moore,
Zbylut J. Twardowski,
Corresponding Author
Harold L. Moore
Department of Medicine, Division of Nephrology, University of Missouri, Columbia, Missouri, U.S.A.
* Harold L. Moore, MA, MA436 Health Sciences Center, University of Missouri, One Hospital Drive, Columbia, MO 65211, U.S.A. email: [email protected]Search for more papers by this authorZbylut J. Twardowski
Department of Medicine, Division of Nephrology, University of Missouri, Columbia, Missouri, U.S.A.
Search for more papers by this authorHarold L. Moore,
Zbylut J. Twardowski,
Corresponding Author
Harold L. Moore
Department of Medicine, Division of Nephrology, University of Missouri, Columbia, Missouri, U.S.A.
* Harold L. Moore, MA, MA436 Health Sciences Center, University of Missouri, One Hospital Drive, Columbia, MO 65211, U.S.A. email: [email protected]Search for more papers by this authorZbylut J. Twardowski
Department of Medicine, Division of Nephrology, University of Missouri, Columbia, Missouri, U.S.A.
Search for more papers by this authorAbstract
Background: Soft, cuffed indwelling catheters are used for hemodialysis access and intravenous infusions. The majority of these catheters are removed as a result of infection caused by contamination of the catheter hub during the connection/disconnection procedures. To prevent clot formation in the lumen, these catheters are routinely “locked” with heparin or some other anticoagulant. None of the anticoagulants commonly used as locking solutions demonstrates any significant bactericidal properties. The primary goal of this study was the development of a catheter locking method that retains anticoagulant properties at the catheter tip and bactericidal properties at the catheter hub. The second goal was to find a solution that possesses excellent bactericidal properties but is not detrimental in the event of injection into the patient's blood stream. The bactericidal properties of acidified, concentrated saline (ACS) were compared to concentrated trisodium citrate and to commonly used bactericidal agents such as povidone iodine, sodium hypochlorite, and chlorhexidine.
Methods: In preliminary studies, the rate of diffusion of solutes was measured in glass tubes. In another set of experiments, the mixing of two solutions (anticoagulant and bactericide) separated by an air bubble (“air-bubble method”) was observed in stationary and moving systems. The final series of studies compared the bactericidal properties of ACS to other bactericidal solutions mentioned above.
Results: The solutions diffused swiftly in the glass tubes, and by the third day, both solutions were mixed. The air-bubble method prevented mixing in both stationary and moving systems. The bactericidal properties of ACS were superior to all other tested solutions.
Conclusions: The proposed method of catheter locking with anticoagulant at the catheter tip and ACS at the catheter hub separated by an air bubble is a promising technique and clinical studies are warranted.
References
- 1 Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother. 2002; 46(6): 1674–1679.
- 2 Capdevila JA, Gavalda J, Fortea J, Lopez P, Martin MT, Gomis X, Pahissa A. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect. 2001; 7(4): 206–212.
- 3 Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis. 1993; 167(4): 920–924.
- 4 Elliott TS, Curran A. Effects of heparin and chlorbutol on bacterial colonization of intravascular cannulae in an in vitro model. J Hospital Infect. 1989; 14(3): 193–200.
- 5 Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993; 168(2): 400–407.
- 6 Liñares J, Sitges-Serra A, Garau J, Pérez JL, Martín R. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol. 1985; 21(3): 357–360.
- 7 Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis. 1993; 167(2): 487–490.
- 8 Sitges-Serra A. Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer. 1999; 7(6): 391–395.
- 9 Sitges-Serra A, Hernández R, Maestro S, Pi-Suñer T, Garcés JM, Segura M. Prevention of catheter sepsis: The hub. Nutrition. 1997; 13(suppl 4): 30S–35S.
- 10 Sitges-Serra A, Linares J, Garau J. Catheter sepsis: The clue is the hub. Surgery. 1985; 97(3): 355–357.
- 11 Stiges-Serra A, Puig P, Linares J, Pérez JL, Farreró N, Jaurrieta E, Garau J. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. J Parenter Enteral Nutr. 1984; 8(6): 668–672.
- 12 Weist K, Sperber A, Dietz E, Ruden H. Contamination of stopcocks mounted in administration sets for central venous catheters with replacement at 24 hrs versus 72 hrs: A prospective cohort study [abstract]. Infect Control Hospital Epidemiol. 1997; 18(5 pt 2): 24.
- 13 Pearson ML. Guidelines for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hospital Epidemiol. 1996; 17(7): 438–473.
- 14 Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis. 1986; 154(4): 579–589.
- 15 Schwab SJ, Beathard G. The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int. 1999; 56(1): 1–17.
- 16 Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999; 10(5): 1045–1049.
- 17 Holm I, Wretlind A. Prophylaxis against the infection and septicemia in parenteral nutrition via central intravenous catheter. Acta Chir Scand. 1975; 141(3): 173–181.
- 18 Hesselvik F, Schildt B, Nilehn B. Long term parenteral therapy by percutaneous tunneled silicone central venous catheter: A follow-up of 300 catheters. Clin Nutr. 1982; 1: 117–124.
- 19 Sheth NK, Franson TR, Rose HD, Buckmire FLA, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol. 1983; 18(5): 1061–1063.
- 20 Ashkenazi S, Weiss E, Drucker MM. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity. J Lab Clin Med. 1986; 107(2): 136–140.
- 21 Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. IV. Scanning electron microscopy of intravenous catheters invaded by yeasts. Zentralbl Bakteriol Mikrobiol Hyg [B]. 1981; 173(6): 419–424.
- 22 Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg [B]. 1981; 173(5): 285–292.
- 23 Nachnani GH, Lessin LS, Motomiya T, Jensen WN, Bodey GP. Scanning electron microscopy of thrombogenesis on vascular catheter surfaces. N Engl J Med. 1972; 286(3): 139–140.
- 24 Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology of catheter-associated sepsis: Correlation with thrombogenicity. Arch Surg. 1977; 112(12): 1497–1499.
- 25 Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun. 1991; 59(1): 279–288.
- 26 Herrmann M, Lai QJ, Albrecht RM, Mosher DF, Proctor RA. Adhesion of Staphylococcus aureus to surface-bound platelets: Role of fibrinogen/fibrin and platelet integrins. J Infect Dis. 1993; 167(2): 312–322.
- 27 Nilsson M, Frykberg L, Flock JI, Pei L, Lindberg M, Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun. 1998; 66(6): 2666–2673.
- 28 DeMuri GP, Hostetter MK. Evidence for a β 1 integrin fibronectin receptor in Candida tropicalis. J Infect Dis. 1996; 174(1): 127–132.
- 29 Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999; 284(5418): 1318–1322.
- 30 Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet. 1984; 1(8373): 365–367.
- 31 Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis. 1990; 161(1): 37–40.
- 32 Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun. 1986; 54(1): 13–20.
- 33 Shiau AL, Wu CL. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiol Immunol. 1998; 42(1): 33–40.
- 34 Branchini ML, Pfaller MA, Rine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood catheter isolates of Candida parapsilosis. J Clin Microbiol. 1994; 32(2): 452–456.
- 35 Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy. 2000; 20(4): 394–399.
- 36 Capdevila JA. Catheter-related infection: An update on diagnosis, treatment, and prevention. Int J Infect Dis. 1998; 2(4): 230–236.
- 37 Sodemann K, Lubrich-Birkner I, Berger O, Baumert J, Feldmer B, Von Hodenberg E. Gentamicin/sodium-citrate mixture as antibiotic-lock technique for salvage and prevention of catheter-related infections—A four year trial. (abstract). J Am Society Nephrol. 1997; 8(September): 173A.
- 38 Kirby RR, Labato EB. Hypertonic saline resuscitation in anesthesia and surgery. Curr Anesthesiol Rep. 2000; 2(4): 257–258.
- 39 Oliveira RP, Velasco I, Soriano FG, Friedman G. Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care. 2002; 6(5): 418–423.
- 40 Gong R, Lindberg J, Abrams J, Whitaker WR, Wade CE, Gouge S. Comparison of hypertonic saline solutions and dextran in dialysis-induced hypotension. J Am Soc Nephrol. 1993; 3(11): 1808–1812.
- 41 Daugirdas JT, Ing TS. Handbook of Dialysis, 2nd ed. Boston: Little, Brown, 1994: 116.
- 42 Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, Hanley DF, Ulatowski JA. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998; 26(6): 1118–1122.
- 43 Tseng M-Y, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke. 2003; 34(6): 1389–1396.
- 44 Nasimi A, Cardona J, Berthier M, Oriot D. Hydrochloric acid infusion for treatment of severe metabolic alkalosis in a neonate. Clin Pediatr. 1996; 35(5): 271–272.
- 45 Knutsen OH. New method for administration of hydrochloric acid in metabolic alkalosis. Lancet. 1983; 1(8331): 953–956.
- 46 Kwun KB, Boucherit T, Wong J, Richards Y, Bryan-Brown CW. Treatment of metabolic alkalosis with intravenous infusion of concentrated hydrochloric acid. Am J Surg. 1983; 146(3): 328–330.
- 47 Harken AH, Gabel RA, Fencl V, Moore FD. Hydrochloric acid in the correction of metabolic alkalosis. Arch Surg. 1975; 110(7): 819–821.
- 48 Abouna GM, Veazey PR, Terry DB Jr. Intravenous infusion of hydrochloric acid for treatment of severe metabolic alkalosis. Surgery. 1974; 75(2): 194–202.
- 49 Rothe KF. Hydrochloric acid for metabolic alkalosis (Letter). Lancet. 1983; 1(8337): 1332.
- 50 Brimioulle S, Berre J, Dufaye P, Vincent JL, Degaute JP, Khan RJ. Hydrochloric acid infusion for treatment of metabolic alkalosis associated with respiratory acidosis. Crit Care Med. 1989; 17(3): 232–236.
- 51 Worthley LI. Intravenous hydrochloric acid in patients with metabolic alkalosis and hypercapnia. Arch Surg. 1986; 121(10): 1195–1198.
- 52 McDonald BR, Steiner RW. Rapid infusion of HCl during citrate dialysis to counteract alkalosis (Letter). Clin Nephrol. 1990; 33(5): 255–256.
- 53 Chen HF, Kou YR. Vagal and mediator mechanism underlying the tachypnea caused by pulmonary embolism in dogs. J Appl Physiol. 2000; 88(4): 1247–1253.
- 54 Yoshida M, Alkalay I, Rotman HH, Kimbel P. Pulmonary vascular changes following air embolism in the dog. Arch Int Physiol Biochim. 1978; 86(2): 317–325.
- 55 Oppenheimer MJ, Durant TM, Lynch P. Body position in relation to venous air embolism and the associated cardiovascular-respiratory changes. Am J Med Sci. 1953; 225(4): 362–373.
- 56 Ordway CB. Air embolus via CVP catheter without positive pressure. Ann Surg. 1974; 179(4): 479–481.
- 57 Bedell EA, Berge KH, Losasso TJ. Paradoxic air embolism during venous air embolism: Transesophageal echocardiographic evidence of transpulmonary air passage. Anesthesiology. 1994; 80(4): 947–950.
- 58 Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59(1): 17–20.
- 59 Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left atrial shunting in a healthy population: Detection by Valsalva maneuver contrast echocardiography. Am J Cardiol. 1984; 53(10): 1478–1480.
- 60 Yu ASL, Levy E. Paradoxical cerebral air embolism from a hemodialysis catheter. Am J Kidney Dis. 1997; 29(3): 453–455.
- 61 Flanagan JP, Gradisar IA, Gross RJ, Kelly TR. Air embolus—A lethal complication of subclavian venipuncture. N Engl J Med. 1969; 281(9): 488–489.
- 62 Vik A, Jenssen BM, Brubakk AO. Paradoxical air embolism in pigs with a patent foramen ovale. Undersea Biomed Res. 1992; 19(5): 361–374.
- 63 Levine RA, Teichholz LE, Goldman ME, Steinmetz MY, Baker M, Meltzer RS. Microbubbles have intracardiac velocities similar to those of red blood cells. J Am Coll Cardiol. 1984; 3(1): 28–33.
- 64 Kerr AJ, Buck T, Chia K, Chow CM, Fox E, Levine RA, Picard MH. Transmitral doppler: A new transthoracic contrast method for patent foramen ovale detection and quantification. J Am Coll Cardiol. 2000; 36(6): 1959–1966.
- 65 Durant TM, Long J, Oppenheimer M. Pulmonary (venous) air embolism. Am Heart J. 1947; 33(3): 269–281.
- 66 Arahal DR, Marquez MC, Volcani BE, Schleifer KH, Ventosa A. Reclassification of Bacillus marismortui as Salibacillus marismortui comb. nov. Int J Syst Evol Microbiol. 2000; 50(4): 1501–1503.
- 67 Kis-Papo T, Oren A, Wasser SP, Nevo E. Survival of filamentous fungi in hypersaline Dead Sea water. Microb Ecol. 2003; 45(2): 183–190.
- 68 Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Color Atlas and Textbook of Diagnostic Microbiology, 4th ed. Philadelphia: Lippincott, 1992: 254.
- 69 Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32(9): 1249–1272.
- 70 Goldman MP, Kaplan RP, Oki LN, Cavender PA, Strick RA, Bennett RG. Sclerosing agents in the treatment of telangiectasia: Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model. Arch Dermatol. 1987; 123(9): 1196–1201.
- 71 Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasques KA, Smeltzer BD, Ing TS. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int. 2000; 4: 22–31.
- 72 FDA Issues Warning on triCitrasol Dialysis Catheter Anticoagulant [Internet]. FDA Talk Paper. Rockville, MD: Food and Drug Administration, U.S. Department of Health and Human Services, Public Health Service, 2000 Apr 14. Available from: www.fda.gov/bbs/topics/ANSWERS/ANS01009.html
Citing Literature
